Mahana™ IBS is an FDA-cleared, clinically validated, prescription digital therapeutic designed for individuals diagnosed with irritable bowel syndrome (IBS). It is a 3-month digital therapy program that aims to reduce the severity of IBS symptoms. With Mahana IBS, users can track symptoms and triggers, manage flare-ups, change unhelpful behaviors and thoughts, and develop personalized techniques for lasting IBS relief. The program utilizes IBS targeted cognitive behavioral therapy to help users build a healthier brain-gut relationship, decrease symptom severity, and improve overall well-being. It is authorized by the FDA and has been clinically proven to reduce IBS symptom severity, with long-lasting relief lasting up to one year. Mahana IBS is intended to be used in conjunction with other IBS treatments and has no known side effects.